Death at the opposite ends of the Eurasian continent: mortality trends in Taiwan and the Netherlands, 1850-1945 - Edited by Theo Engelen, John R. Shepherd, and Wen-shan Yang

Adolescent and young adult (AYA) cancer patients, aged 15–39 years at primary cancer diagnosis, form a distinct, understudied, and underserved group in cancer care. This study aimed to assess long-term trends in incidence, survival, and mortality of AYA cancer patients within the Netherlands. Data on all malignant AYA tumours diagnosed between 1990–2016 (n = 95,228) were obtained from the Netherlands Cancer Registry. European age-standardised incidence and mortality rates with average annual percentage change (AAPC) statistics and five-year relative survival rates were calculated. The overall cancer incidence increased from 54.6 to 70.3 per 100,000 person-years (AAPC: +1.37%) between 1990–2016, and increased for both sexes individually and for most cancer types. Five-year relative survival overall improved from 73.7% in 1990–1999 to 86.4% in 2010–2016 and improved for both sexes and most cancer types. Survival remained poor (<60%) for rhabdomyosarcoma, lung, stomach, liver, bladder, and pancreatic carcinomas, among others. Mortality rates among male AYAs overall declined from 10.8 to 6.6 (AAPC: −1.64%) and from 14.4 to 10.1 per 100,000 person-years (AAPC: −1.81%) for female AYAs since 1990. Mortality rates remained unchanged for male AYAs aged 20–24 and 25–29 years. In conclusion, over the past three decades, there has been a considerable increase in cancer incidence among AYAs in the Netherlands. Meanwhile, the survival improved and the mortality overall declined. Survival at five-years now well exceeds above 80%, but did not do so for all cancer types.

Download Full-text

Mortality trends in middle aged and older women in the Netherlands: beneficial effect of menopausal hormone therapy

Maturitas ◽

10.1016/j.maturitas.2015.02.089 ◽

2015 ◽

Vol 81 (1) ◽

pp. 127

Author(s):

Ingrid Pinas ◽

Niels Erich ◽

Dorly Deeg

Keyword(s):

The Netherlands ◽

Beneficial Effect ◽

Hormone Therapy ◽

Older Women ◽

Menopausal Hormone Therapy ◽

Middle Aged ◽

Mortality Trends

Download Full-text

Coronary heart disease mortality trends in the Netherlands 1972-2007

Heart ◽

10.1136/hrt.2010.206565 ◽

2011 ◽

Vol 97 (7) ◽

pp. 569-573 ◽

Cited By ~ 44

Author(s):

I. Vaartjes ◽

M. O'Flaherty ◽

D. E. Grobbee ◽

M. L. Bots ◽

S. Capewell

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

The Netherlands ◽

Coronary Heart Disease Mortality ◽

Mortality Trends ◽

Disease Mortality

Download Full-text

Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study

Neuro-Oncology Advances ◽

10.1093/noajnl/vdab183 ◽

2021 ◽

Author(s):

Raoull Hoogendijk ◽

Jasper van der Lugt ◽

Dannis van Vuurden ◽

Leontien Kremer ◽

Pieter Wesseling ◽

...

Keyword(s):

The Netherlands ◽

Malignant Tumors ◽

Survival Rates ◽

Population Based ◽

Cns Tumors ◽

Mortality Trends ◽

Netherlands Cancer Registry ◽

Incidence And Mortality ◽

Pilocytic Astrocytomas ◽

Over Time

Abstract Introduction Survival of children with central nervous system (CNS) tumors varies largely between countries. For the Netherlands, detailed population-based estimation of incidence, survival and mortality of pediatric CNS tumors are lacking but are needed to evaluate progress. Methods All CNS tumors diagnosed in patients <18 years during 1990-2017 were selected from the Netherlands Cancer Registry. Other than pilocytic astrocytomas, non-malignant tumors were included since 2000. Incidence and mortality trends were evaluated by Average Annual Percentage Change (AAPC). Changes over time in Five-year Observed Survival (5-year OS) were evaluated by Poisson regression models adjusted for follow-up time. Results Between 1990 and 2017, 2057 children were diagnosed with a malignant CNS tumor and 885 with a pilocytic astrocytoma. During 2000-17, 695 children were diagnosed with other non-malignant CNS tumors. Incidence rates of malignant tumors remained stable, while pilocytic astrocytomas and other non-malignant tumors increased by 2.0% and 2.4% per year, respectively. 5-year OS rates improved for all groups; however, improvement for malignant tumors was not constant over time. The contribution of malignant tumors located at the optic nerve tumors was 1% in 2000-09. However, shifting from pilocytic astrocytomas, increased to 6% in 2010-17, impacting survival outcomes for malignant tumors. Conclusion Survival rates of CNS tumors improved over time, but was not accompanied by a decreasing mortality rate. The observed temporary survival deterioration for malignant tumors appears to be related to changes in diagnostics and registration practices. Whether differences in treatment regimens contribute to this temporary decline in survival needs to be verified.

Download Full-text

PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the Netherlands

Value in Health ◽

10.1016/j.jval.2011.08.751 ◽

2011 ◽

Vol 14 (7) ◽

pp. A369

Author(s):

J.A. Overbeek ◽

F.J.A. Penning-Van Beest ◽

R.M.C. Herings ◽

I. Agodoa

Keyword(s):

Heart Failure ◽

The Netherlands ◽

Hospital Mortality ◽

Mortality Trends ◽

Patients With Heart Failure

Download Full-text

Contribution of amenable mortality to life expectancy differences between the Dutch Caribbean islands of Aruba and Curaçao and the Netherlands

Revista Panamericana de Salud Pública ◽

10.26633/rpsp.2020.38 ◽

2020 ◽

Vol 44 ◽

pp. 1

Author(s):

Soraya P. A. Verstraeten ◽

Hans A. M. van Oers ◽

Johan P. Mackenbach

Keyword(s):

Breast Cancer ◽

Health Care ◽

Life Expectancy ◽

The Netherlands ◽

Population Data ◽

Mortality Trends ◽

Caribbean Islands ◽

Amenable Mortality ◽

Dutch Caribbean ◽

Circulatory Diseases

Objective. To identify specific health care areas whose optimization could improve population health in the Dutch Caribbean islands of Aruba and Curaçao. Methods. Comparative observational study using mortality and population data of the Dutch Caribbean islands and the Netherlands. Mortality trends were calculated, then analyzed with Joinpoint software, for the period 1988–2014. Life expectancies were computed using abridged life tables for the most recent available data of all territories (2005–2007). Life expectancy differences between the Dutch Caribbean and the Netherlands were decomposed into cause-specific contributions using Arriaga’s method. Results. During the period 1988–2014, levels of amenable mortality have been consistently higher in Aruba and Curaçao than in the Netherlands. For Aruba, the gap in amenable mortality with the Netherlands did not significantly change during the study period, while it widened for Curaçao. If mortality from amenable causes were reduced to similar levels as in the Netherlands, men and women in Aruba would have added, respectively, 1.19 years and 0.72 years to their life expectancies during the period 2005–2007. In Curaçao, this would be 2.06 years and 2.33 years. The largest cause-specific contributions were found for circulatory diseases, breast cancer, perinatal causes, and nephritis/nephrosis (these last two causes solely in Curaçao). Conclusions. Improvements in health care services related to circulatory diseases, breast cancer, perinatal deaths, and nephritis/nephrosis in the Dutch Caribbean could substantially contribute to reducing the gap in life expectancy with the Netherlands. Based on our study, we recommend more in-depth studies to identify the specific interventions and resources needed to optimize the underlying health care areas.

Download Full-text